Lipografting Versus Steroid Injections for Treatment of Carpal Tunnel Syndrome

• Status: Unknown status
• Trial end date: 2019-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This study applies the regenerative properties of autologous fat transfer to treat mild to moderate carpal tunnel syndrome in comparison to the current standard of care, corticosteroid treatment. The investigators hypothesize the fat transfer would prevent scar formation and aid in nerve excursion along the canal (while the neoangiogenic and regenerative growth factors could stimulate nerve regeneration) better than the standard of care treatment.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Columbia University
• Collaborator: Orthopaedic Scientific Research Foundation
• Treatments: Cortisone

Criteria

Inclusion Criteria:

• primary mild to moderate carpal tunnel syndrome (CTS)

• report symptoms longer than 6 months

• night pain

• weakness

• sensory deficits

• fluent English-speaking adult (>18)

Exclusion Criteria:

• <18 years old

• Non-english speaking

• injection in past 6 months

• previous hand surgery

• previous hand trauma (fracture or dislocation)